Menu
US
Shop
Request a Quote
Contact Us
US
precise-cell-engineering1920x640
Whitepaper

Precise cell engineering

Explore the capabilities of the Pin-point™ base editing platform, designed for precise, multiplex gene editing in human T cells and iPSCs. Our white paper provides an in-depth analysis of how this technology enables targeted genetic modifications with improved safety compared to traditional methods. Key highlights include:

  • High-efficiency Multiplex Editing: Achieve simultaneous gene modifications in clinically relevant cell types.
  • Enhanced Safety Profile: Minimize off-target effects and chromosomal translocations.
  • Comprehensive Single-Cell Analysis: Leverage CITE-Seq to assess the functional impact of gene edits.

Pin-point™ base editing reagents are available for research use only and are not for diagnostic use or direct administration into humans or animals. The Pin-point™ base editing platform technology is available for clinical or diagnostic study and commercialization under a commercial license from Revvity with further development from the licensee.

For research use only. Not for use in diagnostic procedures

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Precise cell engineering

Download Whitepaper